K23HL150311/HL/NHLBI NIH HHS/United States[Grants and Funding] - Search Results

Save citations to file

Your saved search

Your RSS Feed

Year	Number of Results
2022	1
2023	1
2024	1
2025	0

Page 1

SGLT2 Inhibitor Prescribing in Cardiovascular-Kidney-Metabolic Syndrome.

Beers BD, Chebrolu B, Stern GM, Buckley LF, Vaduganathan M, Bhatt DL, Bernier TD. Beers BD, et al. Am J Cardiovasc Drugs. 2024 Nov;24(6):841-844. doi: 10.1007/s40256-024-00687-9. Epub 2024 Oct 9. Am J Cardiovasc Drugs. 2024. PMID: 39382621 No abstract available.

Contemporary Trends in the Use of and Expenditures on Digoxin in the United States.

Alahmed AA, Lauffenburger JC, Vaduganathan M, Aldemerdash A, Ting C, Fatani N, Fanikos J, Buckley LF. Alahmed AA, et al. Am J Cardiovasc Drugs. 2022 Sep;22(5):567-575. doi: 10.1007/s40256-022-00540-x. Epub 2022 Jun 24. Am J Cardiovasc Drugs. 2022. PMID: 35739347 Free PMC article.

Effects of Intensive Systolic Blood Pressure Lowering on End-Stage Kidney Disease and Kidney Function Decline in Adults With Type 2 Diabetes Mellitus and Cardiovascular Risk Factors: A Post Hoc Analysis of ACCORD-BP and SPRINT.

Tawfik YMK, Van Tassell BW, Dixon DL, Baker WL, Fanikos J, Buckley LF. Tawfik YMK, et al. Diabetes Care. 2023 Apr 1;46(4):868-873. doi: 10.2337/dc22-2040. Diabetes Care. 2023. PMID: 36787937 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3 results

Results by year